Skip to main content

Royalty Pharma Plc Cl A(RPRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Royalty Pharma Plc Cl A

110 East 59th Street
New York NY 10022 USA
P: 212-883-0200
http://www.royaltypharma.com

Profile

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.

Key Executives

NameTitle
Pablo LegorretaCEO/Chairman of the Board/Director/Founder
Terrance CoyneCFO/Chief Accounting Officer/Executive VP

More from The Globe

Bullish on NextEra Energy Inc.
Monica Rizk
number cruncher
Ten transportation stocks to watch as oil prices rise
For Number Cruncher column in Globe Investor/ROB only.
The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022. THE CANADIAN PRESS/Nathan Denette
Insider Report: Chair sells $5-million from this stock yielding 5.8% that’s doubled in under a year
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022. THE CANADIAN PRESS/Nathan Denette
Canaccord reworks U.S. leadership in wake of regulatory settlement
The logo for Canaccord Genuity is shown in Toronto on Wednesday, March 8, 2023. THE CANADIAN PRESS/Staff
Bullish on FirstEnergy Corp.
Monica Rizk
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.